Precision Therapeutics COO steps down
Insight Weekly: Loan delinquencies up; US money supply falls; coal employment grows
Insight Weekly: Loan-to-deposit ratio rises; inventory turnovers ebb; miners add female leaders
Debt Ceiling Debate: IR Teams Should Prepare for Potential Market Downturns
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Eagen, Minn.-based Precision Therapeutics Inc. said David Johnson stepped down as COO of the company.
Johnson was appointed senior vice president of operations of the company's Skyline Medical business unit.
Precision Therapeutics manufactures systems for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care.
